|
Status |
Public on Jan 24, 2015 |
Title |
HCC38_12h+Wnt3a_rep2 |
Sample type |
RNA |
|
|
Source name |
HCC38
|
Organism |
Homo sapiens |
Characteristics |
wnt3a treatment: yes time after treatment (hours): 12 cell line: HCC38
|
Treatment protocol |
Cells were seeded in six-well plates, serum starved overnight, and then treated with Wnt3a for the indicated times (6, 12 or 24 hours). Triplicates for each condition were included in the experiment.
|
Growth protocol |
HCC38 and MDA-MB-468 cells were obtained from the American Type Culture Collection and authenticated in 2013 by short tandem repeat profiling. MDA-MB-468 cells were maintained in RPMI-1640 containing Glutamax and supplemented with 10% FBS. HCC38 cells were cultured in RPMI-1640 with Glutamax containing 10% FBS, 1.5g/L sodium bicarbonate, 10mM Hepes and 1mM sodium pyruvate. Cells were cultured at 37°C in a 5% CO2 humidified incubator.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was extracted with the RNeasy Mini Kit from Qiagen (Courtaboeuf, France) following the manufacturer’s recommendations.
|
Label |
biotin
|
Label protocol |
After RNA quality and quantity controls, samples were hybridized onto Gene st 1.1 Affymetrix chips. Samples were processed as described on the website of the company.
|
|
|
Hybridization protocol |
standard Affymetrix protocol
|
Scan protocol |
standard Affymetrix protocol
|
Data processing |
The data were analyzed with the brainarray HuGene11stv1_Hs_ENTREZG version 14 custom chipset definition file for the HuGene11stv1 affymetrix array. The data were first log2 transformed and normalized with RMA.
|
|
|
Submission date |
Jan 23, 2015 |
Last update date |
Jan 24, 2015 |
Contact name |
Thierry Dubois |
E-mail(s) |
thierry.dubois@curie.fr
|
Organization name |
Institut Curie
|
Department |
Recherche Center
|
Lab |
Breast Cancer Biology Group
|
Street address |
26 rue d’Ulm
|
City |
PARIS |
ZIP/Postal code |
75005 |
Country |
France |
|
|
Platform ID |
GPL15640 |
Series (1) |
GSE65238 |
Transcriptome analysis of Wnt3a-treated triple-negative breast cancer cell lines. |
|